Prevalence of diabetes mellitus in biopsy-positive giant cell arteritis

Jared L Matthews1, David N Gilbert, Bradley K Farris

  • 1University of Oklahoma College of Medicine, Oklahoma City, OK, USA. JMatthews2@med.miami.edu

Abstract

Insights

Patients with diabetes mellitus (DM) are less likely to have biopsy-positive giant cell arteritis (GCA). This finding suggests reconsidering diagnostic suspicion in diabetic patients with potential GCA.

Area of Science:

  • Rheumatology
  • Endocrinology
  • Pathology

Background:

  • Giant cell arteritis (GCA) is a systemic vasculitis.
  • The association between diabetes mellitus (DM) and GCA is not well understood.
  • This study investigates the prevalence of DM in biopsy-positive GCA cases.

Purpose of the Study:

  • To test the hypothesis that patients with DM develop biopsy-positive GCA less frequently than nondiabetic patients.
  • To compare DM prevalence in patients with positive vs. negative temporal artery biopsies (TAB).
  • To conduct a meta-analysis of existing literature on DM and biopsy-proven GCA.

Main Methods:

  • Retrospective study of 215 patients undergoing TAB.
  • Classification of biopsy-positive GCA based on microscopic examination.
  • Definition of DM based on medical history or medication use.
  • Meta-analysis of 8 published studies including 1,401 additional GCA cases.

Main Results:

  • In the study cohort, only 9.1% of biopsy-positive GCA cases had DM.
  • A significantly lower prevalence of DM was observed in biopsy-positive GCA patients compared to those with negative TAB (9.1% vs. 35.7%, P = 0.0006).
  • Meta-analysis revealed a combined DM prevalence of 6.35% in 1,401 biopsy-proven GCA cases.

Conclusions:

  • The low frequency of biopsy-positive GCA in diabetic patients warrants consideration when evaluating suspected GCA.
  • Further research is necessary to elucidate the interaction between DM and GCA.
  • Diagnostic suspicion for GCA may need adjustment in diabetic individuals.

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...